Dr. Chi Young Ok, MD

Dr. Ok practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Ok's NPI, 1437315892, was assigned on August 5, 2008. Dr. Ok graduated from Yonsei University College of Medicine in 2004. Dr. Ok's Massachusetts license number on file is 237148.

Dr. Ok's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Ok's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ok practices. Vendor and product names are available with a free account.

Anatomic pathology and clinical pathology is Dr. Ok's primary specialty in the NPI Registry, under taxonomy code 207ZP0102X. Dr. Ok is board certified in clinical informatics by the American Board of Pathology. Dmand AI has Dr. Ok's licenses on file in 2 states: Massachusetts and Texas.

CMS data shows 1,573 Medicare services from Dr. Ok across 12 procedure codes in 2024, for 740 Medicare patients. Medicare paid $51,104 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 740 Medicare patients who saw Dr. Ok in 2024. The largest group is 65 to 74, with 405 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ok's median patient age at 66, with 45% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Ok for performance year 2024, reported as part of a group. Dr. Ok accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 84 papers to Dr. Ok, published from 2011 to 2025. 2019 was the busiest year, with 12. The most frequent topics are Lymphoma, Mantle-Cell, Biomarkers, Tumor and Immunophenotyping. Dr. Ok has published most often in Am J Hematol. Dr. Ok's most frequent co-authors are Leonard Jeffrey Medeiros, MD, Sa A. Wang, MD and Sanam Loghavi, MD.

Dr. Ok graduated from Yonsei University College of Medicine in 2004.

Dr. Ok is in network with 5 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 4. Check the plan with the practice before a visit.